Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in SEER — Seer, Inc.

CIK 1362033 LONDON, X0
Back to SEER Full portfolio

Position in SEER

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$306,309
-$20,457 QoQ
Shares Held
184,524
-5.1% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 59 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SEER Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. SEER ranks #106 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 187,337 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in SEER

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $306,309 184,524
2026-03-31 $326,766 194,504
2025-12-31 $478,296 261,364
2025-09-30 $535,267 246,667
2025-06-30 $400,353 187,081
2025-03-31 $113,872 67,380
2024-12-31 $206,788 89,519
2024-09-30 $251,899 127,868
2024-06-30 $72,833 43,353
2024-03-31 $127,476 67,093
2023-12-31 $31,897 16,442